Skip to main content

Peer Review reports

From: A re-assessment of 4CMenB vaccine effectiveness against serogroup B invasive meningococcal disease in England based on an incidence model

Original Submission
18 Apr 2021 Submitted Original manuscript
13 Jun 2021 Reviewed Reviewer Report
5 Jul 2021 Reviewed Reviewer Report
6 Jul 2021 Reviewed Reviewer Report - Stefan Michael Scholz
2 Sep 2021 Author responded Author comments - Lorenzo Argante
Resubmission - Version 2
2 Sep 2021 Submitted Manuscript version 2
17 Sep 2021 Reviewed Reviewer Report
27 Sep 2021 Reviewed Reviewer Report
14 Oct 2021 Author responded Author comments - Lorenzo Argante
Resubmission - Version 3
14 Oct 2021 Submitted Manuscript version 3
22 Oct 2021 Reviewed Reviewer Report
8 Nov 2021 Author responded Author comments - Lorenzo Argante
Resubmission - Version 4
8 Nov 2021 Submitted Manuscript version 4
Publishing
25 Nov 2021 Editorially accepted
11 Dec 2021 Article published 10.1186/s12879-021-06906-x

You can find further information about peer review here.

Back to article page